Biophysical Characterization of the New Human Ether-A-Go-Go-Related Gene Channel Opener NS3623 [N-(4-Bromo-2-(1H-tetrazol-5-yl)-phenyl)-N′-(3′-trifluoromethylphenyl)urea]
Authors:
- Thomas Goldin DinessTDThomas Goldin Diness
- Torsten ChristTCTorsten Christ
- Erich WettwerEWErich Wettwer
- Ursula RavensURUrsula Ravens
- Søren-Peter OlesenSOSøren-Peter Olesen
- Morten GrunnetMGMorten Grunnet
- 1 October 2006
- journal article
- research article
- Published by Elsevier in Molecular Pharmacology
- Vol. 70 (4) , 1319-1329
Abstract
Within the field of new antiarrhythmic compounds, the interesting idea of activating human ether-a-go-go-related gene (HERG1) potassium channels has recently been introduced. Potentially, drugs that increase HERG1 channel activity will augment the repolarizing current of the cardiac myocytes and stabilize the diastolic interval. This may make the myocardium more resistant to events that cause arrhythmias. We here present the compound N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N′-(3′-trifluoromethylphenyl)urea (NS3623), which has the ability to activate HERG1 channels expressed in Xenopus laevis oocytes with an EC50 value of 79.4 μM. Exposure of HERG1 channels to NS3623 affects the voltage-dependent release from inactivation, resulting in a half-inactivation voltage that is rightward-shifted by 17.7 mV. Moreover, the compound affects the time constant of inactivation, leading to a slower onset of inactivation of the macroscopic HERG1 currents. We also characterized the ability of NS3623 to increase the activity of different mutated HERG1 channels. The mutants S620T and S631A are severely compromised in their ability to inactivate. Application of NS3623 to any of these two mutants did not result in increased HERG1 current. In contrast, application of NS3623 to the mutant F656M increased HERG1 current to a larger extent than what was observed with wild-type HERG1 channels. Because the amino acid F656 is essential for high-affinity inhibition of HERG1 channels, it is concluded that NS3623 has a dual mode of action, being both an activator and an inhibitor of HERG1 channels. Finally, we show that NS3623 has the ability to shorten action potential durations in guinea pig papillary muscle.Keywords
This publication has 23 references indexed in Scilit:
- Mechanism of Action of a Novel Human ether-a-go-go-Related Gene Channel ActivatorMolecular Pharmacology, 2006
- Activation of Human ether-a-go-go-Related Gene Potassium Channels by the Diphenylurea 1,3-Bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643)Molecular Pharmacology, 2006
- Novel Potent Human Ether-à-Go-Go-Related Gene (hERG) Potassium Channel Enhancers and Their in Vitro Antiarrhythmic ActivityMolecular Pharmacology, 2005
- Discovery of a Small Molecule Activator of the Human Ether-a-go-go-Related Gene (HERG) Cardiac K+ ChannelMolecular Pharmacology, 2005
- DCPIB is a novel selective blocker of ICl,swell and prevents swelling‐induced shortening of guinea‐pig atrial action potential durationBritish Journal of Pharmacology, 2001
- Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKS potassium channelNature, 1996
- KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium currentNature, 1996
- Fast inactivation causes rectification of the IKr channel.Journal of General Physiology, 1996
- HERG, a Human Inward Rectifier in the Voltage-Gated Potassium Channel FamilyScience, 1995
- A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channelCell, 1995